Please Wait
Applying Filters...
menu
    • menu
    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Lasofoxifene

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sermonix Pharma receives Chinese approval of IND application for lasofoxifene
    Sermonix Pharma receives Chinese approval of IND application for lasofoxifene

    08 Jun 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169632&sid=2

    PHARMABIZ
    08 Jun 2024
    Share Share
    Sermonix Announces Results of Phase 2 Study of Lasofoxifene vs. Fulvestrant
    Sermonix Announces Results of Phase 2 Study of Lasofoxifene vs. Fulvestrant

    13 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/13/2515038/0/en/Sermonix-Pharmaceuticals-Announces-Results-of-Phase-2-Study-of-Lasofoxifene-vs-Fulvestrant-in-Postmenopausal-Women-With-Locally-Advanced-or-Metastatic-ER-HER2-Breast-Cancer-and-an-.html

    GLOBENEWSWIRE
    13 Sep 2022
    Share Share
    Sermonix to Present Poster on Phase 2 Study of Lasofoxifene in with Eli Lilly
    Sermonix to Present Poster on Phase 2 Study of Lasofoxifene in with Eli Lilly

    04 Dec 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/12/03/2139311/0/en/Sermonix-to-Present-Poster-on-Phase-2-Study-of-Lasofoxifene-in-Combination-with-Eli-Lilly-and-Company-s-Abemaciclib-at-Virtual-San-Antonio-Breast-Cancer-Symposium-2020.html

    GLOBENEWSWIRE
    04 Dec 2020
    Share Share